Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apex Healthcare Bhd's earnings per share without non-recurring items for the
three
months ended in Sep. 2025 was RM0.02.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was RM0.09.
During the past 12 months, Apex Healthcare Bhd's average earnings per share (NRI) Growth Rate was -21.40% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 8.80% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 26.60% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 17.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Apex Healthcare Bhd's EPS without NRI or its related term are showing as below:
XKLS:7090'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0 Med: 9.55 Max: 92.5
Current: 8.8
During the past 13 years, Apex Healthcare Bhd's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 92.50% per year. The lowest was 0.00% per year. And the median was 9.55% per year.
XKLS:7090's 3-Year EPS without NRI Growth Rate is not ranked
in the Medical Distribution industry.
Industry Median: 2.6
vs XKLS:7090: 8.80
Apex Healthcare Bhd's EPS (Basic) for the
three
months ended in Sep. 2025 was RM0.02.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 was RM0.09.
Apex Healthcare Bhd (XKLS:7090) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Apex Healthcare Bhd EPS without NRI Related Terms
Apex Healthcare Bhd EPS without NRI Historical Data
* Premium members only.
The historical data trend for Apex Healthcare Bhd's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7090 vs MCK, COR, CAH: EPS without NRI Comparison
For the Medical Distribution subindustry, Apex Healthcare Bhd's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd PE Ratio without NRI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.09
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Healthcare Bhd (XKLS:7090) has a EPS without NRI of RM0.09 as of Sep. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Apex Healthcare Bhd and its competitors.
Is Apex Healthcare Bhd's EPS without NRI too high?
Apex Healthcare Bhd's current EPS without NRI is RM0.09. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's EPS without NRI compare to MCK and COR?
Apex Healthcare Bhd's EPS without NRI of RM0.09 can be compared against companies in the Medical Distribution industry. The industry median EPS without NRI is 2.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Distribution company?
The median EPS without NRI among Medical Distribution companies is 2.60, based on 101 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median EPS without NRI is 2.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current EPS without NRI is RM0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current EPS without NRI of RM0.09. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current EPS without NRI is RM0.09. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current EPS without NRI is RM0.09 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
EPS without NRI: RM0.09
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
